Chin Hur, MD, MPH

Publications

• Ho W, Broughton DE, Donelan K, Gazelle GS, Hur C.Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population.AJR Am J Roentgenol. 2010 Aug;195(2):393-7.
  20651195
• Yeh JM, Ho W, Hur C.Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival.Gastrointest Endosc. 2010 Jul;72(1):33-43.
  20430384
• Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ.Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.Cancer. 2010 Jun 15;116(12):2941-53.
  20564399
• Yachimski P, Lee RA, Tramontano A, Nishioka NS, Hur C.Secular Trends in Patients Diagnosed with Barrett's Esophagus.Dig Dis Sci. 2010 Apr;55(4):960-6.
  19798573
• Hur C, Hayeck TJ, Yeh JM, Richards EB, Spechler SJ, Gazelle GS, Kong CY.Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.PLoS ONE. 2010;5(3):e9483.
  20208996
• Huang ES, Gazelle GS, Hur C.Consensus Guidelines in the Management of Branch Duct Intraductal Papillary Mucinous Neoplasm: A Cost-Effectiveness Analysis.Dig Dis Sci. 2010 Mar;55(3):852-60.
  19834805
• Greenblatt WH, Hur C, Knudsen AB, Evans JA, Chung DC, Gazelle GS.Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis.Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2677-84.
  19789369
• Hur C,Broughton DE,Kong CY,Ozanne EM,Richards EB,Truong T,Gazelle GS.Patient Preferences for the Chemoprevention of Colorectal Cancer.Dig Dis Sci. 2009 Oct;54(10):2207-14.
  19057995
• Pandharipande PV,Harisinghani MG,Ozanne EM,Specht MC,Hur C,Lee JM,Gazelle GS.Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis.AJR Am J Roentgenol. 2008 Nov;191(5):1308-19.
  18941062
• Hur C,Broughton DE,Ozanne E,Yachimski P,Nishioka NS,Gazelle GS.Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus.Am J Gastroenterol. 2008 Oct;103(10):2432-42.
  18775019
• Yachimski P,Nishioka NS,Richards E,Hur C.Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy.Clin Gastroenterol Hepatol. 2008 Nov;6(11):1206-11.
  18619919
• Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS.Radiofrequency Ablation versus Nephron-sparing Surgery for Small Unilateral Renal Cell Carcinoma: Cost-effectiveness Analysis.Radiology. 2008 Jul;248(1):169-78.
  18458248
• Yeh JM,Kuntz KM,Ezzati M,Hur C,Kong CY,Goldie SJ.Development of an empirically calibrated model of gastric cancer in two high-risk countries.Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1179-87.
  18483340
• Hur C, Yachimski P.How useful is histologic confirmation of intestinal metaplasia in patients with long-segment Barrett's esophagus?.Nat Clin Pract Gastroenterol Hepatol. 2008 Mar;5(3):140-1.
  18212774
• Choi MY, Lauwers GY, Hur C, Willett CG, Chung DC.Microsatellite instability is frequently observed in rectal cancer and influenced by neoadjuvant chemoradiation.Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1584.
  17674996
• Hur C, Chung DC, Schoen RE, Gazelle GS.The management of small polyps found by virtual colonoscopy: results of a decision analysis.Clin Gastroenterol Hepatol. 2007 Feb;5(2):237-44.
  17296532
• Hur C.Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?.Clin Gastroenterol Hepatol. 2007 Mar;5(3):307-9.
  17257904
• Schoen RE, Hur C.What is the clinical importance of small polyps with regard to colorectal cancer screening?.Nat Clin Pract Gastroenterol Hepatol. 2006 Sep;3(9):488-9.
  16951664
• Hur C, Wittenberg E, Nishioka NS, Gazelle GS.Quality of life in patients with various Barretts esophagus associated health states.Health Qual Life Outcomes. 2006 Aug 2;4(1):45.
  16884539
• Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE.Risks and Benefits of Infliximab for the Treatment of Crohn's Disease.Clin Gastroenterol Hepatol. 2006 Aug;4(8):1017-24; quiz 976.
  16843733
• Hur C, Chan AT, Tramontano AC, Gazelle GS.Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.Ann Pharmacother. 2006 Jun;40(6):1052-63.
  16720709
• Hur C, Gazelle GS, Hsu EH, Halpern EF, Podolsky DK.The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography.Clin Gastroenterol Hepatol. 2005 Nov;3(11):1124-7.
  16271344
• Jo WS, Bandipalliam P, Shannon KM, Niendorf KB, Chan-Smutko G, Hur C, Syngal S, Chung DC.Correlation of polyp number and family history of colon cancer with germline MYH mutations.Clin Gastroenterol Hepatol. 2005 Oct;3(10):1022-8.
  16234049
• Hur C, Wittenberg E, Nishioka NS, Gazelle GS.Patient preferences for the management of high-grade dysplasia in Barrett's esophagus.Dig Dis Sci. 2005 Jan;50(1):116-25.
  15712648
• Hur C, Simon LS, Gazelle GS.Analysis of aspirin-associated risks in healthy individuals.Ann Pharmacother. 2005 Jan;39(1):51-7.
  15590881
• Hur C, Gazelle GS, Zalis ME, Podolsky DK.An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand.Gastroenterology. 2004 Nov;127(5):1312-21.
  15521000
• Hur C, Simon LS, Gazelle GS.The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.Cancer. 2004 Jul 1;101(1):189-97.
  15222006
• Hur C, Nishioka NS, Gazelle GS.Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.J Natl Cancer Inst. 2004 Feb 18;96(4):316-25.
  14970280
• Hur C, Nishioka NS, Gazelle GS.Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia.Dig Dis Sci. 2003 Jul;48(7):1273-83.
  12870783
• Brown NA, Kovacs A, Lui CR, Hur C, Zaia JA, Mosley JW.Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV.Lancet. 1988 Nov 12;2(8620):1146.
  2903363